Ovarian Cancer Trial, Recruiting NCT03911297 Sponsor: Imperial College London Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT03911297
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman who has been told by a doctor that you may have polycystic ovary syndrome (PCOS)
  • You are between 18 and 70 years old
  • You are able to understand the study information and agree to take part

Who may not be able to join:

  • You are currently pregnant or breastfeeding
  • You have serious kidney problems or significant liver problems (confirm with trial site for specific test values)
  • You have another significant health condition that the trial doctor believes could put you at risk or affect the results of the study
  • You have taken part in a clinical trial involving an experimental medicine in the last 12 weeks
  • You have used steroid medications (such as cortisone or prednisone) in any form in the last six months
  • You are currently taking, or have taken in the last six months, any medicines known to affect hormones or metabolism (confirm with trial site for specific medicines)
  • You have used hormonal contraception taken by mouth or applied to the skin (such as the pill or a patch) in the last three months
  • You have had a contraceptive implant in place at any point during the last twelve months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Wiebke Arlt, University of Birmingham

Phone: +447852146611

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
14 August 2019
Est. completion
31 December 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Metabolic risk

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov